Neurotransmitter Specific, Cellular-Resolution Functional Brain Mapping Using Receptor Coated Nanoparticles: Assessment of the Possibility. by Forati, Ebrahim et al.
UC San Diego
UC San Diego Previously Published Works
Title
Neurotransmitter Specific, Cellular-Resolution Functional Brain Mapping Using Receptor 






















Functional Brain Mapping Using Receptor
Coated Nanoparticles: Assessment of the
Possibility
Ebrahim Forati1*, Abas Sabouni1, Supriyo Ray2, Brian Head3, Christian Schoen4,
Dan Sievenpiper1
1 Electrical and Computer Engineering Department, University of California San Diego, La Jolla, CA 92098,
United States of America, 2 Biomedical Sciences, University of California San Diego, La Jolla, CA 92098,
United States of America, 3Department of Anesthesiology, University of California San Diego, La Jolla, CA
92098, United States of America, 4 Nanopartz Inc., Loveland, CO 80537, United States of America
* forati@ieee.org
Abstract
Receptor coated resonant nanoparticles and quantum dots are proposed to provide a cellu-
lar-level resolution image of neural activities inside the brain. The functionalized nanoparti-
cles and quantum dots in this approach will selectively bind to different neurotransmitters in
the extra-synaptic regions of neurons. This allows us to detect neural activities in real time
by monitoring the nanoparticles and quantum dots optically. Gold nanoparticles (GNPs)
with two different geometries (sphere and rod) and quantum dots (QDs) with different sizes
were studied along with three different neurotransmitters: dopamine, gamma-Aminobutyric
acid (GABA), and glycine. The absorption/emission spectra of GNPs and QDs before and
after binding of neurotransmitters and their corresponding receptors are reported. The
results using QDs and nanorods with diameter 25nm and aspect rations larger than three
were promising for the development of the proposed functional brain mapping approach.
Introduction
Chemical messengers released by neurons, known as neurotransmitters, enable nerve fibers to
communicate signals to the other nerves in their vicinity. Since various aspects of brain cir-
cuitry are modulated by neurotransmitters [1], an understanding of neurotransmitter’s dynam-
ics helps to comprehend brain functions. This is difficult to study due to their small size and
low concentration. So far scientists have identified more than 100 neurotransmitters and more
are yet to be discovered. Dopaminergic neurons, which use dopamine as a neurotransmitter for
neural signaling [2], are of special importance as defects in this type of neural signaling have
been associated with various disorders such as Parkinson’s disease [3], Alzheimer’s disease [4],
and schizophrenia [5–8].
PLOSONE | DOI:10.1371/journal.pone.0145852 December 30, 2015 1 / 13
OPEN ACCESS
Citation: Forati E, Sabouni A, Ray S, Head B,
Schoen C, Sievenpiper D (2015) Neurotransmitter
Specific, Cellular-Resolution Functional Brain
Mapping Using Receptor Coated Nanoparticles:
Assessment of the Possibility. PLoS ONE 10(12):
e0145852. doi:10.1371/journal.pone.0145852
Editor: Elena A. Rozhkova, Argonne National
Laboratory, UNITED STATES
Received: September 29, 2015
Accepted: December 9, 2015
Published: December 30, 2015
Copyright: © 2015 Forati et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was funded by UC San Diego
Center for Brain Activity Mapping. The funders had
no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: One of the authors, Christian
Schoen, is CEO of Nanopartz Inc. This does not alter
the authors’ adherence to PLOS ONE policies on
sharing data and materials.
In recent years investigators have developed a number of methods to detect acute changes
in neurotransmission [9]. Most of these methods were based on molecular imaging techniques,
in which changes in receptor kinetic parameters were detected by administering a radio-labeled
ligand and measuring its concentration by Positron Emission Tomography (PET), Single Pho-
ton Emission Computed Tomography (SPECT) camera, or Functional MRI (FMRI) [10–15].
The idea in this work is to develop a technique whereby extra-synaptic dopamine (and
other types of neurotransmitters) can be detected with cellular level resolution based on the
optical properties of plasmonic nanoparticels, i.e. Localized Surface Plasmon Resonance
(LSPR), or QDs. One advantage of this approach is that multiple neurotransmitters can poten-
tially be identified simultaneously by using different nanoparticles. Resonant nanoparticles and
QDs in this approach are functionalized with the appropriate receptors, as shown in Fig 1. This
paper is specifically focused on developing solution-based dopamine sensors. As Fig 2 depicts
the proposed idea schematically, functionalized nanoparticles are to be distributed over the
neurons and within the synapses. During neural activities, the sparsely released dopamine in
the extra-synaptic region of neurons will bind to the functionalized nanoparticles and will be
detected optically by means of spectroscopy (reflection or photoluminescence). It is expected
that the binding of neurotransmitters to the nanoparticles would change the optically reflected/
transmitted light that can be detected effectively. In the following, we first study GNPs as the
neurotransmitter’s detectors. Then, in the last section, we consider QDs and compare them
with GNPs.
Surface Plasmons (SPs) are the collective charge oscillations at the surface of plasmonic
materials. SPs coupled with photons form the composite quasi-particles known as Surface Plas-
mon Polaritons (SPPs) [16–18]. Theoretically, by solving Maxwell’s equations on both sides of
a surface, it is easy to show that 3D materials with negative bulk permittivities (e.g., noble met-
als) or 2D materials with non-zero imaginary surface conductivities (e.g., graphene [19]) are
Fig 1. Two different nanorods functionalized with different receptors. Neurotransmitters selectively bind
to the associated nanorods. Figure is drawn by E.F.
doi:10.1371/journal.pone.0145852.g001
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essential in order to support the SPP. In addition, if the size of the 3D plasmonic material is
limited (i.e. it forms a particle), the geometrical resonance of the particle will combine with the
SPP to form LSPR. Unlike SPR, the excitation of LSPR can be easily done by plane waves which
makes them suitable for practical applications [20, 21]. In other words, under illumination
with a broadband source, plasmonic particles generate high intensity localized electric fields
bound to their surface, making them good candidates for label-free bio-sensing applications
[22, 23]. The shape, size, and material of the particle determine the localized electric field prop-
erties such as the intensity, the frequency, and the spatial distribution. Due to the inherent loss
in plasmonic materials, and the loss in the material surrounding the particles, portions of the
excitation wave will be absorbed and converted to heat in and around the surface of the nano-
particles. Besides being used in heat ablation therapy techniques [24–26], the absorbed energy
can be used for sensing applications, simply by monitoring its absorption frequency spectrum
[27–29]. At frequencies closer to the particle’s LSPR, the localized electric field and therefore
the energy absorption (conversion to heat) is stronger. That is, any changes in the dielectric
properties of the material in the immediate vicinity of nanoparticles will be reflected in the the
absorption spectrum of the mixture either as a shift and/or as a change in its curvature. The
sensitivity of the absorption spectrum of nanoparticles to the dielectric properties of their
immediate vicinity is proportional to their localized electric field intensity which is in turn lim-




in which Elocal and Eincident are the intensity of the localized and the incident electric fields,
respectively [30–32]. Among different noble metals, silver provides the highest electric filed
concentration, as it has the lowest loss and can provide the highest resonant quality factor.
However, silver nanoparticles have practical issues such as fast oxidization. The next suitable
noble metal is gold, which is the most common material in LSPR based sensors. Gold has
higher loss compared to silver, but has less practical limitations. Finding the resonance quality
Fig 2. The proposed concept of optical real time imaging of neural activities using functionalized
resonant nano-structures. Figure is drawn by A.S.
doi:10.1371/journal.pone.0145852.g002
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factor of plasmonic nanoparticles can be done using the classical computational (and some-
times analytical) electromagnetic techniques. As a known result, the quality factor of spheroids
(and rods) increases as their aspect ratio increases [33, 34]. That is, prolate spheroids have
larger quality factor than spheres and oblate spheroids.
Methodology (GNPs)
Several gold nanoparticles were functionalized using different neurotransmitter receptors, and
their absorption spectra are reported pre and post binding of neurotransmitters. We used com-
mercially available GNPs (both spheres and rods) in order to keep the experiments reproduc-
ible for future investigations without concerns about the variabilities in nanoparticles
synthesis. Table 1 lists the nanoparticles used along with their basic characteristics and Table 2
contains the different neurotransmitters and receptors which were used in this study. Sample
TEM images of the studied GNPs are shown in Fig 3 as well.
To standardize the method, we used antibody against dopamine (Antidop) and cleaned it
off using abcam anitbody cleaning kit. It is to be noted that Antidop would act as a receptor for
dopamine released at the synaptic cleft. After determining the concentration, we used 3μg/ml
concentration of antibodies to conjugate it to nanospheres. We left it overnight in cold room
with gentle shaking for the antibodies to conjugate and then washed prior conjugating it with
dopamine. The dopamine was freshly constituted in PBS and 100 micromoles were added to
the antibodies bound to nanospheres accompanied by gentle shaking. The mixture was let to
stand for 45 minutes followed intermittent gentle shaking. Carbonyl groups at the C-terminal
of the Antidop interacts with the free amine groups of the nanopheres through electrostatic
interaction. In spherical GNPs, the antibody cysteine could bind to the Au displacing the
adsorbed citrate or other carboxylic acids used as capping agents. However, nanorods were
capped by a Hexadecyltrimethylammonium bromide (CTAB) micelle which does lend itself to
antibody cysteine binding. Therefore, the CTAB was replaced with a 12-Mercaptododecanoic
acid NHS ester added at 1μg per 50 OD-mL of nanorods. After purification via centrifugation,
100 micrograms of Antidop were added and the mixture vortexed for 30 minutes. The NHS
binds to the primary amines of the Antidop within 10–15 minutes. Three more purifications
Table 1. The studied GNPs (fromNanopartz Inc.).
Type Label Diameter [nm] Aspect ratio First abs. peak [nm] Second abs. peak [nm] Part no.
Rod NR3 25 2.9 518 689 C12-25-700
Rod NR5 25 2.4 517 662 C12-25-650
Rod NR6 10 5.9 511 946 C12-10-980
Sphere NS5 80 1 546 - C11-80
Sphere NS6 125 1 606 - C11-125
doi:10.1371/journal.pone.0145852.t001
Table 2. List of the studied Neurotransmitters and receptors.
Name Type Label Provider Part no.
Dopamine Neurotransmitter Dop Sigma-Aldrich H8502
GABA Neurotransmitter Gab Sigma-Aldrich A2129
Glycine Neurotransmitter Gly Sigma-Aldrich G7126
Anti-GABA antibody Receptor Antigab Sigma-Aldrich A2052
Anti-Dopamine antibody Receptor Antidop abcam ab6427
Anti-Glycine antibody Receptor Antigly abcam ab9442
doi:10.1371/journal.pone.0145852.t002
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via centrifugation were used. All conjugations (spheres and nanorods) were done at 25 C and
pH 7.4. Then, the sample was transferred into the well of 96 well plate and the absorption spec-
trum is recorded using Tecan infinite m200 plate reader.
We defined our standard results set as the comparison among three measured absorption
spectra for each GNP: 1) bare GNP, 2) functionalized GNP with the receptor, and 3) neuro-
transmitter bound to the functionalized GNP. All of the absorption spectra were normalized to
their maxima as we only relied on the frequency shifts. In each standard results set, the fre-
quency shift (often redshift) in the GNP’s absorption spectrum after functionalizing ensured
the proper attachment of the receptor.
Results and Discussion (GNPs)
Fig 4(a) shows the standard results set for NS5 and NS6 with Antidop and Dop as the receptor
and the neurotransmitter, respectively. It is evident that both nanospheres’ spectra showed
detectable redshifts after adding Dop to the functionalized nanospheres. Moreover, as was
expected, the larger nanosphere exhibited larger redshifts due to the larger surface area. Fig 4
(b) also reports the standard results set for NS5 and NS6 but using Antigly and Gly as the
receptor and the analyte, respectively, which showed redshifts 1nm post binding of the analyte.
As a verification, the same result was repeated using the same size nanosphere from a different
company (Innova Bioscience Inc.) and similar results were observed. It is worth mentioning
that, due to the extreme confinement of the localized electric fields of LSPRs to the GNP’s sur-
face, GNPs could only interact with the neurotransmitters if they were bound to each other.
After repeating the same experiments with smaller nanospheres than 80nm, we concluded
that the shifts are too small to be detectable. The redshift in nanospheres with sizes larger than
80nm were repeatable and therefore proved the proposed concept. However, the sensitivity was
still too small (2nm for NS6) to be useful in practical instrument designs. Besides increasing
their surface area, the sensitivity of GNPs to neurotransmitters can be enhanced by choosing
GNPs with higher resonance quality factor which in turn increases the localized electric fields
intensities on the GNPs’ surface. Fig 5 reveals the standard results set for NR3 using Antidop
and Dop as the receptor and the neurotransmitter, respectively. A redshift of 10nm post bind-
ing of Dop to the functionalized nanorod was observable in the second absorption peak in
Fig 3. Example TEM images of the studies GNPs: NR6 (left), and NS5 (right) as introduced in Table 1.
doi:10.1371/journal.pone.0145852.g003
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Fig 4. The standard results set for NS5 and NS6 nanospheres using a) Antidop as the receptor and
Dop as the neurotransmitter, and b) Antigab as the receptor and Gab as the neurotransmitter. The
numbers in parenthesizes report the peak wavelength of each curve in units of nm.
doi:10.1371/journal.pone.0145852.g004
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Fig 5. The enhanced shift in the spectrum of the nanorod compared to nanospheres is due to
its higher resonance quality factor which in turn leads to a higher localized electric field based
on Eq (1). Equivalently, by forming and solving an electromagnetic scattering problem, it is
straight forward to show that prolate spheroids (which can be approximated by nanorods)
have higher absorption cross section than spheres and oblate spheroids [34]. In fact, in the
extreme limits of a spheroid, the absorption cross section of a lossy needle is several orders of
magnitude larger than that of a disk (see Fig 2 in [34] which applied to any lossy spheroid on a
different scale). Higher light absorption means stronger interaction with light, larger localized
electric fields around the particle, and higher sensitivity to the environment.
The first and the second absorption peaks in nanorods’ absorption spectra were associated
with transverse and longitudinal resonance modes, respectively. As a control, Gab was also
added to the NR3 functionalized with Antidop which did not have any noticeable effect on its
spectrum. Gab (GABA) is also a neurotransmitter which acts on inhibitory synapse.
As a further investigation, NR5 and NR6 were functionalized with Antidop and Antigly,
respectively. The two functionalized GNPs were then mixed together and Gly or Dop was
added to the mixture consequently. The idea in this measurement set was to examine the possi-
bility of discerning neurotransmitters using a mixture GNPs with different sizes so that each
size was functionalized with a specific receptor. Fig 6(a) shows the spectra of NR5 and NR6
before and after binding to the receptors. The shift in the peak wavelength confirmed proper
Fig 5. The standard results set for NR3 using Antidop as the receptor and Dop as the neurotransmitter. The numbers in parenthesizes report the peak
wavelengths of each curve in units of nm.
doi:10.1371/journal.pone.0145852.g005
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Fig 6. a) Absorption spectra of NR5 and NR6 before and after functionalizing with the receptors, and
b) using the mixture of the functionalized GNPs to detect both Dop and Gab. The numbers in
parenthesizes report the peak wavelengths of each curve in units of nm.
doi:10.1371/journal.pone.0145852.g006
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GNP functionalizations. Note that unlike the nanorods with diameter 25nm (and nano-
spheres), the longitudinal resonance of the nanorods with diameter 10nm experienced a blue-
shift post binding of Antidop (this was also observed in measurements using different nanor-
ods). On the other hand, after mixing the two functionalized GNPs, both of the longitudinal
peaks experienced a larger redshift (canceling the blue shift of the second peak), which could
be due to the charge effects in the solution. Fig 6(b) includes the spectrum of the mixture of the
bare nanorods with two longitudinal resonance peaks at 667nm and 957nm which the first
peak moved to 683nm post binding of antibodies. The first and the second peaks redshifted
7nm and 33nm, respectively, post binding of Gly which were different form the 13nm and the
52nm redshifts post binding of Dop.
Replacing GNPs with QDs
The absorption spectra of gold nanorods showed around 10nm redshift after binding to neuro-
transmitters. However, the peak in GNPs spectra is wide, due to the loss, which is not desirable
in detecting the peak shift. In other words, the ratio of the peak shift (after binding to the ana-
lyte) to the peak width is a better measure of detection convenience in our approach. Therefore,
nanoparticles with much higher resonance quality factor are preferred in this method. Alterna-
tively, instead of GNPs, we can use QDs which typically have very narrow emission spectra.
Quantum dots are two/multi level quantum systems which can emit photons with energies
equal or greater than their bandgap, if pumped with high enough energy photons. The bandgap
of a QD, as well as its excited and ground levels quantization, are mainly controlled by its size
and material. However, particles in the vicinity of QD, along with the ambient medium, impose
extra restrictions on the emitted spectrum, which is often explained via the Purcell effect [35].
In [36, 37], effects of plasmonic materials (GNPs and graphene) on the emission spectrum of a
quantum dot are studied theoretically by forming and solving a quantum master equation [36,
38]. We studied two commercially available CdSSe/ZnS core/shell QDs from Ocean NanoTech
[39] with emission peaks at 450nm (part no. QSA-450) and 540nm (part no. QSA-540). The
full width of half maximum (FWHM) of the emission spectra of the studied QDs were 35nm.
QDs were sourced from Ocean NanoTech, and were amine capped. 1:1 Molar ratio of active
amine sites were activated with Thermo Fisher BS3 and then conjugated to the antibody. BS3
(Sulfo-DSS) is bis(sulfosuccinimidyl)suberate, an amine-to-amine crosslinker that is homobi-
functional and water soluble. Excess 5:1 antibody was added and then purification was per-
formed by dialysis. It was determined that extra amine groups were not readily purified when
the QDs were received. Therefore, a pre-purification using dialysis was completed. all conjuga-
tions were performed at 25 C and pH 7.4 in PBS. QDs were pumped at 300nm wavelength and
their emission spectra were measured using a florescence spectrophotometer. Fig 7 shows the
standard results set for QSA-450 using Antigly as the receptor and Gly as the neurotransmitter.
The emission peak of QSA-450 was shifted 6nm after binding to the neurotransmitter. The
ratio of the peak shift to the FWHM for QSA-450 is 0.18, which is twice as the 0.09 ratio for
NR6. This makes QD a definitely better choice than GNP to be used in our approach. More-
over, the excitation and emission wavelengths are different in QDs (the excitation is at a
smaller wavelength, 300nm in our experiments) which makes emission detection much easier.
This is a great advantage over GNPs whose scattering is at the same wavelength and much
weaker than the excitation. Similar to GNPs, mixture of different QDs coated with different
receptors can be used to discern neurotransmitters. Fig 8 includes the emission spectrum of the
mixture of QSA-450 and QSA-540 with peaks at 451nm and 538nm. Then, QSA-450 and
QSA-540 were coated with Antigly and Antidop, respectively. The emission spectra of the
functionalized mixture before and after adding Gly and Dop are shown in Fig 8. The first peak
Neurotransmitter Detection Using Nanoparticles
PLOS ONE | DOI:10.1371/journal.pone.0145852 December 30, 2015 9 / 13
in the spectrum of the functionalized mixture shifts 6nm post binding of Gly while the second
peak remains almost at the same wavelength (with the tolerence of 1nm). Likewise, the second
peak shifts 8nm post biding of Dop. This is exactly what we intended, as Dop(Gly) can only
attach to and interact with QSA-540(QSA-450). Therefore, only the peak associated with QSA-
540(QSA-450) changes in the mixture emission spectrum. Dop(Gly) cannot interact with
QSA-540(QSA-450) because their distance is too large (since they are not brought together by
receptors).
In summary, this paper provides a good solid lead for functional brain mapping using
GNPs and QDs for dopamine, glycine and GABA sensing neurons. The large frequency shifts
in the spectrum of the mixture of nanorods, as well as its specificity to different neurotransmit-
ters, confirmed the proposed functional brain mapping techniques. However, the broad
absorption peak of GNPs is an obstacle in detecting the peak shift. Finding a set of nanoparti-
cles with much higher quality factor (e.g. dimers) and a range of resonance frequencies can
ensure practicality of using GNPs. As another approach, in order to improve detection, QDs
were used instead of GNPs. Since the emission spectrum of a QD is narrow, its peak shift to its
FWHP ratio is large, which helps the detection of neurotransmitters. Moreover, the excitation
wavelength of QDs is different than their emission spectra, which benefits the detection fur-
ther. Whether these GNPs and QDs are toxic to the cells and tissues is yet to be confirmed. It
will be also important to test the sensitivity of these GNPs and QDs once they penetrate the
tissues.
Fig 7. a) The standard results set for QSA-450 using Antigab as the receptor and Gab as the neurotransmitter. The pump wavelength was 300nm and
the numbers in parenthesizes report the peak wavelength of each curve in units of nm.
doi:10.1371/journal.pone.0145852.g007
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